First Occurrence of the OXA-198 Carbapenemase in

Anti-Bacterial Agents / pharmacology Bacterial Proteins / genetics Carbapenem-Resistant Enterobacteriaceae / drug effects Carbapenems / pharmacology Cephalosporins / pharmacology Citrobacter / drug effects Drug Resistance, Multiple, Bacterial / genetics Humans Male Microbial Sensitivity Tests Penicillins / pharmacology Plasmids / genetics beta-Lactamases / genetics
Citrobacter Citrobacter pasteurii carbapenemase integrons plasmid β-lactamases

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
24 03 2020
Historique:
received: 30 07 2019
accepted: 21 12 2019
pubmed: 15 1 2020
medline: 12 1 2021
entrez: 15 1 2020
Statut: epublish

Résumé

A carbapenem-resistant

Identifiants

DOI: 10.1128/AAC.01471-19 PMID: 31932369 PMC: PMC7179269
pubmed: 31932369
pii: AAC.01471-19
doi: 10.1128/AAC.01471-19
pmc: PMC7179269
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
Carbapenems 0
Cephalosporins 0
Penicillins 0
beta-Lactamases EC 3.5.2.6
carbapenemase EC 3.5.2.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

J Antimicrob Chemother. 2013 Jan;68(1):34-9
pubmed: 22969080
Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):E4161-9
pubmed: 27402745
Antimicrob Agents Chemother. 2011 Oct;55(10):4828-33
pubmed: 21788473
Int J Syst Evol Microbiol. 2016 Dec;66(12):5575-5599
pubmed: 27620848
Genome Res. 2017 May;27(5):722-736
pubmed: 28298431
Emerg Infect Dis. 2012 Sep;18(9):1503-7
pubmed: 22932472
Antimicrob Agents Chemother. 2018 May 25;62(6):
pubmed: 29581118
J Antimicrob Chemother. 2014 Mar;69(3):623-7
pubmed: 24275115
Antimicrob Agents Chemother. 2012 Jan;56(1):559-62
pubmed: 22083465
J Bacteriol. 2005 Apr;187(7):2377-85
pubmed: 15774881
Pediatr Neonatol. 2013 Apr;54(2):137-40
pubmed: 23590960
J Antimicrob Chemother. 2018 Apr 1;73(4):909-915
pubmed: 29365094
Antimicrob Agents Chemother. 2011 Jan;55(1):349-54
pubmed: 20956589
Antimicrob Agents Chemother. 2017 Jan 24;61(2):
pubmed: 27855079
Clin Microbiol Rev. 2009 Jan;22(1):161-82, Table of Contents
pubmed: 19136439

Auteurs

Rémy A Bonnin (RA)

EA7361, Université Paris-Sud, Université Paris-Saclay, LabEx Lermit, Bacteriology-Hygiene Unit, APHP, Hôpital Bicêtre, EERA "Evolution and Ecology of Resistance to Antibiotics" Unit, Institut Pasteur-APHP-Université Paris Sud, Le Kremlin-Bicêtre, France remy.bonnin@u-psud.fr.
Associated French National Reference Center for Antibiotic Resistance "Carbapenemase-producing Enterobacteriaceae," Le Kremlin-Bicêtre, France.

Agnès B Jousset (AB)

EA7361, Université Paris-Sud, Université Paris-Saclay, LabEx Lermit, Bacteriology-Hygiene Unit, APHP, Hôpital Bicêtre, EERA "Evolution and Ecology of Resistance to Antibiotics" Unit, Institut Pasteur-APHP-Université Paris Sud, Le Kremlin-Bicêtre, France.
Associated French National Reference Center for Antibiotic Resistance "Carbapenemase-producing Enterobacteriaceae," Le Kremlin-Bicêtre, France.

Lauraine Gauthier (L)

EA7361, Université Paris-Sud, Université Paris-Saclay, LabEx Lermit, Bacteriology-Hygiene Unit, APHP, Hôpital Bicêtre, EERA "Evolution and Ecology of Resistance to Antibiotics" Unit, Institut Pasteur-APHP-Université Paris Sud, Le Kremlin-Bicêtre, France.
Associated French National Reference Center for Antibiotic Resistance "Carbapenemase-producing Enterobacteriaceae," Le Kremlin-Bicêtre, France.

Cécile Emeraud (C)

EA7361, Université Paris-Sud, Université Paris-Saclay, LabEx Lermit, Bacteriology-Hygiene Unit, APHP, Hôpital Bicêtre, EERA "Evolution and Ecology of Resistance to Antibiotics" Unit, Institut Pasteur-APHP-Université Paris Sud, Le Kremlin-Bicêtre, France.
Associated French National Reference Center for Antibiotic Resistance "Carbapenemase-producing Enterobacteriaceae," Le Kremlin-Bicêtre, France.

Delphine Girlich (D)

EA7361, Université Paris-Sud, Université Paris-Saclay, LabEx Lermit, Bacteriology-Hygiene Unit, APHP, Hôpital Bicêtre, EERA "Evolution and Ecology of Resistance to Antibiotics" Unit, Institut Pasteur-APHP-Université Paris Sud, Le Kremlin-Bicêtre, France.

Aimie Sauvadet (A)

EA7361, Université Paris-Sud, Université Paris-Saclay, LabEx Lermit, Bacteriology-Hygiene Unit, APHP, Hôpital Bicêtre, EERA "Evolution and Ecology of Resistance to Antibiotics" Unit, Institut Pasteur-APHP-Université Paris Sud, Le Kremlin-Bicêtre, France.
Associated French National Reference Center for Antibiotic Resistance "Carbapenemase-producing Enterobacteriaceae," Le Kremlin-Bicêtre, France.

Garance Cotellon (G)

EA7361, Université Paris-Sud, Université Paris-Saclay, LabEx Lermit, Bacteriology-Hygiene Unit, APHP, Hôpital Bicêtre, EERA "Evolution and Ecology of Resistance to Antibiotics" Unit, Institut Pasteur-APHP-Université Paris Sud, Le Kremlin-Bicêtre, France.
Associated French National Reference Center for Antibiotic Resistance "Carbapenemase-producing Enterobacteriaceae," Le Kremlin-Bicêtre, France.

Thomas Jové (T)

INSERM, CHU Limoges, RESINFIT, University of Limoges, Limoges, France.

Laurent Dortet (L)

EA7361, Université Paris-Sud, Université Paris-Saclay, LabEx Lermit, Bacteriology-Hygiene Unit, APHP, Hôpital Bicêtre, EERA "Evolution and Ecology of Resistance to Antibiotics" Unit, Institut Pasteur-APHP-Université Paris Sud, Le Kremlin-Bicêtre, France.
Associated French National Reference Center for Antibiotic Resistance "Carbapenemase-producing Enterobacteriaceae," Le Kremlin-Bicêtre, France.
ORCID: 0000-0001-6596-7384

Thierry Naas (T)

EA7361, Université Paris-Sud, Université Paris-Saclay, LabEx Lermit, Bacteriology-Hygiene Unit, APHP, Hôpital Bicêtre, EERA "Evolution and Ecology of Resistance to Antibiotics" Unit, Institut Pasteur-APHP-Université Paris Sud, Le Kremlin-Bicêtre, France.
Associated French National Reference Center for Antibiotic Resistance "Carbapenemase-producing Enterobacteriaceae," Le Kremlin-Bicêtre, France.
ORCID: 0000-0001-9937-9572

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › First Occurrence of the OXA-198 Carbapenemase in
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines bactériennes › First Occurrence of the OXA-198 Carbapenemase in
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Enterobacteriaceae résistantes aux carbapénèmes › First Occurrence of the OXA-198 Carbapenemase in
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Carbapénèmes › First Occurrence of the OXA-198 Carbapenemase in
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Céphalosporines › First Occurrence of the OXA-198 Carbapenemase in
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Citrobacter › First Occurrence of the OXA-198 Carbapenemase in
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Multirésistance aux médicaments › Multirésistance bactérienne aux médicaments › First Occurrence of the OXA-198 Carbapenemase in
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › First Occurrence of the OXA-198 Carbapenemase in
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › First Occurrence of the OXA-198 Carbapenemase in
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Pénicillines › First Occurrence of the OXA-198 Carbapenemase in
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Plasmides › First Occurrence of the OXA-198 Carbapenemase in
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Amidohydrolases › bêta-Lactamases › First Occurrence of the OXA-198 Carbapenemase in